|
US6268487B1
(en)
|
1996-05-13 |
2001-07-31 |
Genzyme Transgenics Corporation |
Purification of biologically active peptides from milk
|
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
|
EP0933029A1
(en)
*
|
1998-02-03 |
1999-08-04 |
Xyrofin Oy |
Skimmed milk powder substitute
|
|
EP0947464A1
(en)
*
|
1998-04-01 |
1999-10-06 |
Single Buoy Moorings Inc. |
Fluid transfer boom with coaxial fluid ducts
|
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
|
AU765315B2
(en)
*
|
1998-11-19 |
2003-09-18 |
Pharming Intellectual Property Bv |
Stabilisation of milk from transgenic animals
|
|
US7030289B2
(en)
|
1998-11-19 |
2006-04-18 |
Ppl Therapeutics (Scotland) Ltd |
Stabilization of milk from transgenic animals
|
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
|
ES2706547T3
(es)
|
1998-12-23 |
2019-03-29 |
Pfizer |
Anticuerpos monoclonales humanos para CTLA-4
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
ES2299425T3
(es)
*
|
1999-05-13 |
2008-06-01 |
Gtc Biotherapeutics, Inc. |
Antitrombina iii producida geneticamente y formas mutantes de la misma.
|
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
US20040226053A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
|
NZ527302A
(en)
|
2001-01-05 |
2006-10-27 |
Abgenix Inc |
Antibodies to insulin-like growth factor I receptor
|
|
WO2002072024A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Progenetics Llc |
Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
|
|
AU2002307554A1
(en)
*
|
2001-04-23 |
2002-11-05 |
Abgenix, Inc. |
Anti-alpha3(iv)nc1 monoclonal antibodies and animal model for human anti-glomerular basement membrane autoantibody disease
|
|
JP2005519580A
(ja)
*
|
2001-05-16 |
2005-07-07 |
アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ |
非ヒト動物由来のヒト抗肺炎球菌抗体
|
|
BR0210386A
(pt)
*
|
2001-06-13 |
2004-09-14 |
Taurus Hsa Llc |
Purificação de albumina de soro humano
|
|
AR039067A1
(es)
*
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
US20060253913A1
(en)
*
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
|
US6578724B1
(en)
*
|
2001-12-29 |
2003-06-17 |
United States Can Company |
Connector for use in packaging aerosol containers
|
|
NZ536420A
(en)
*
|
2002-04-12 |
2008-04-30 |
Medarex Inc |
Methods of treatment using CTLA-4 antibodies
|
|
KR100473703B1
(ko)
*
|
2002-08-23 |
2005-03-10 |
한미약품 주식회사 |
형질전환 동물의 젖으로부터 재조합 펩타이드 또는단백질의 정제 방법
|
|
TWI268933B
(en)
*
|
2003-06-10 |
2006-12-21 |
Animal Technology Inst Taiwan |
Method for separating protein from animal milk
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
DOP2005000002A
(es)
|
2004-01-09 |
2005-08-15 |
Pfizer |
"anticuerpos contra madcam"
|
|
US20050197496A1
(en)
*
|
2004-03-04 |
2005-09-08 |
Gtc Biotherapeutics, Inc. |
Methods of protein fractionation using high performance tangential flow filtration
|
|
US20050245444A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Yann Echelard |
Method of using recombinant human antithrombin for neurocognitive disorders
|
|
WO2005112968A2
(en)
*
|
2004-04-30 |
2005-12-01 |
Gtc Biotherapeutics, Inc. |
Method of using recombinant human antithrombin for neurocognitive disorders
|
|
CA2601417C
(en)
|
2004-07-01 |
2018-10-30 |
Novo Nordisk A/S |
Human anti-kir antibodies
|
|
CN101014365B
(zh)
*
|
2004-07-16 |
2011-04-13 |
辉瑞产品公司 |
使用抗-igf-1r抗体联合治疗非血液的恶性肿瘤
|
|
WO2006037604A1
(en)
*
|
2004-10-01 |
2006-04-13 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel antibodies directed to the mammalian eag1 ion channel protein
|
|
US20060121004A1
(en)
*
|
2004-12-07 |
2006-06-08 |
Yann Echelard |
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
|
|
US20060130159A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Nick Masiello |
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
|
|
EP1865986B1
(en)
|
2005-03-08 |
2016-02-17 |
Pfizer Products Inc. |
Anti-ctla-4 antibody compositions
|
|
EP2551282A3
(en)
|
2005-03-23 |
2013-02-13 |
Genmab A/S |
Antibodies against CD38 for treatment of multiple myeloma
|
|
EP1868647A4
(en)
|
2005-03-24 |
2009-04-01 |
Millennium Pharm Inc |
OV064 BINDING ANTIBODIES AND METHOD FOR THEIR USE
|
|
TW200724548A
(en)
*
|
2005-04-25 |
2007-07-01 |
Pfizer |
Antibodies to myostatin
|
|
EP1877444A2
(en)
|
2005-04-26 |
2008-01-16 |
Pfizer, Inc. |
P-cadherin antibodies
|
|
CA2615460A1
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
|
SI2447283T1
(sl)
|
2005-09-07 |
2015-12-31 |
Amgen Fremont Inc. |
Človeška monoklonska protitelesa proti aktivin receptorski kinazi-1 (ALK-1)
|
|
NZ568016A
(en)
|
2005-12-07 |
2011-12-22 |
Medarex Inc |
CTLA-4 antibody dosage escalation regimens
|
|
EP1960431B1
(en)
|
2005-12-15 |
2014-10-01 |
Genmab A/S |
Use of effector-function-deficient antibodies for treatment of auto-immune diseases
|
|
US7531632B2
(en)
*
|
2006-02-16 |
2009-05-12 |
Gtc Biotherapeutics, Inc. |
Clarification of transgenic milk using depth filtration
|
|
AU2007234733A1
(en)
*
|
2006-04-07 |
2007-10-18 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Antibody compositions and methods for treatment of neoplastic disease
|
|
EP2049661A4
(en)
*
|
2006-08-04 |
2012-07-04 |
Pharmathene Inc |
RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE
|
|
KR20090058512A
(ko)
|
2006-08-04 |
2009-06-09 |
아스트라제네카 아베 |
Erbb2에 대한 인간 항체
|
|
TW200821026A
(en)
*
|
2006-09-08 |
2008-05-16 |
Wyeth Corp |
Arginine wash in protein purification using affinity chromatography
|
|
PL2081595T3
(pl)
|
2006-09-26 |
2019-11-29 |
Genmab As |
Anty-cd38 wraz z kortykosteroidami wraz ze środkiem chemioterapeutycznym niebędącym kortykosteroidem, do leczenia guzów nowotworowych
|
|
US8020576B2
(en)
*
|
2006-10-26 |
2011-09-20 |
Delaware Capital Formation, Inc. |
Emergency shutoff valve for use in a fuel dispensing system
|
|
EP2094733A1
(en)
|
2006-11-03 |
2009-09-02 |
U3 Pharma GmbH |
Fgfr4 antibodies
|
|
EP2626372B1
(en)
|
2007-03-29 |
2018-03-21 |
Genmab A/S |
Bispecific antibodies and methods for production thereof
|
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
|
BRPI0820073A2
(pt)
|
2007-11-12 |
2015-06-23 |
U3 Pharma Gmbh |
Anticorpos anti-axl
|
|
WO2015164330A1
(en)
|
2014-04-21 |
2015-10-29 |
Millennium Pharmaceuticals, Inc. |
Anti-psyk antibody molecules and use of same for syk-targeted therapy
|
|
WO2009102509A2
(en)
|
2008-01-10 |
2009-08-20 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
|
HUE029003T2
(en)
|
2008-05-30 |
2017-01-30 |
Xbiotech Inc |
IL-1 alpha antibodies
|
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
|
EP2270053A1
(en)
|
2009-05-11 |
2011-01-05 |
U3 Pharma GmbH |
Humanized AXL antibodies
|
|
MY173390A
(en)
|
2009-10-23 |
2020-01-22 |
Takeda Pharmaceuticals Co |
Anti-gcc antibody molecules and related compositions and methods
|
|
CA2784861A1
(en)
|
2009-12-21 |
2011-07-14 |
Pharmathene, Inc. |
Recombinant butyrylcholinesterases and truncates thereof
|
|
EP2384766A1
(en)
|
2010-05-03 |
2011-11-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel antibody to a carbonic anhydrase
|
|
EP2580243B1
(en)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antibodies against human cd38
|
|
JP6055404B2
(ja)
|
2010-06-15 |
2016-12-27 |
ゲンマブ エー/エス |
組織因子に対するヒト抗体薬物結合体
|
|
WO2012019061A2
(en)
|
2010-08-05 |
2012-02-09 |
Stem Centrx, Inc. |
Novel effectors and methods of use
|
|
MX361929B
(es)
|
2010-11-19 |
2018-12-19 |
Eisai R&D Man Co Ltd Star |
Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.
|
|
AU2011350895B2
(en)
|
2010-12-30 |
2015-05-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Glycols as pathogen inactivating agents
|
|
SA112330278B1
(ar)
|
2011-02-18 |
2015-10-09 |
ستيم سينتركس، انك. |
مواد ضابطة جديدة وطرق للاستخدام
|
|
WO2012136552A1
(en)
|
2011-04-08 |
2012-10-11 |
H. Lundbeck A/S |
ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
|
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
|
RU2623161C2
(ru)
|
2011-04-15 |
2017-06-22 |
Компуджен Лтд. |
Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака
|
|
AU2012278836B2
(en)
*
|
2011-07-07 |
2016-03-10 |
Lfb Usa, Inc. |
Formulations that stabilize proteins
|
|
US9556281B2
(en)
|
2011-08-15 |
2017-01-31 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein A
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
EP2581387B1
(en)
|
2011-10-11 |
2015-09-16 |
Université d'Aix-Marseille |
An anti-HIV-1 Tat monoclonal antibody
|
|
MX2014005570A
(es)
|
2011-11-08 |
2014-05-30 |
Pfizer |
El uso de anticuerpos anti factor estimulante de la colonia de macrofagos para tratar trastornos inflamatorios.
|
|
CN104520324A
(zh)
|
2012-02-24 |
2015-04-15 |
施特姆森特Rx股份有限公司 |
Dll3调节剂及其使用方法
|
|
AU2013252888B2
(en)
|
2012-04-26 |
2018-06-14 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
AU2013260123A1
(en)
|
2012-05-10 |
2014-11-13 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
|
MY177331A
(en)
|
2012-06-15 |
2020-09-12 |
Pfizer |
Improved antagonist antibodies against gdf-8 and uses therefor
|
|
AU2013299986B2
(en)
|
2012-08-07 |
2018-05-17 |
Massachusetts Institute Of Technology |
Anti-dengue virus antibodies and uses thereof
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
EP2956003A2
(en)
|
2013-02-13 |
2015-12-23 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
|
KR20160002713A
(ko)
|
2013-02-13 |
2016-01-08 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
|
|
ES2935257T3
(es)
|
2013-03-15 |
2023-03-03 |
Univ Chicago |
Métodos y composiciones relacionadas con la actividad de las células T
|
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
|
WO2014210540A1
(en)
|
2013-06-28 |
2014-12-31 |
Baylor Research Institute |
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
|
|
CA2916566A1
(fr)
|
2013-07-05 |
2015-01-08 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Matrice de chromatographie d'affinite
|
|
CA2922529A1
(en)
|
2013-08-28 |
2015-03-05 |
Stemcentrx, Inc. |
Novel sez6 modulators and methods of use
|
|
WO2015106281A1
(en)
|
2014-01-13 |
2015-07-16 |
Baylor Research Institute |
Novel vaccines against hpv and hpv-related diseases
|
|
AU2015217149B2
(en)
|
2014-02-11 |
2020-09-10 |
Massachusetts Institute Of Technology |
Novel full spectrum anti-dengue antibody
|
|
EP3166688B1
(en)
|
2014-07-08 |
2024-08-21 |
New York University |
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
|
|
KR102485788B1
(ko)
|
2014-08-27 |
2023-01-09 |
메모리얼 슬로안 케터링 캔서 센터 |
항체, 조성물 및 용도
|
|
MX378108B
(es)
|
2014-09-16 |
2025-03-10 |
Servier Lab |
Anticuerpos anti-met y composiciones.
|
|
EP3271397B1
(en)
|
2015-03-18 |
2021-03-03 |
The Johns Hopkins University |
Inhibitory monoclonal antibody targeting potassium channel kcnk9
|
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
|
GB201512203D0
(en)
|
2015-07-13 |
2015-08-19 |
Lundbeck & Co As H |
Agents,uses and methods
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
GB201512215D0
(en)
|
2015-07-13 |
2015-08-19 |
Lundbeck & Co As H |
Agents,uses and methods
|
|
PT3334761T
(pt)
|
2015-08-13 |
2023-08-17 |
Univ New York |
Moléculas baseadas em anticorpo seletivo para o epítopo {p}ser404 da tau e os seus usos no diagnóstico e tratamento de tauopatias
|
|
US10988528B2
(en)
|
2015-08-13 |
2021-04-27 |
New York University |
Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
|
|
ES2902477T3
(es)
|
2015-12-04 |
2022-03-28 |
Univ Texas |
Péptidos SLC45A2 para inmunoterapia
|
|
JP7029415B2
(ja)
|
2016-07-12 |
2022-03-03 |
ハー・ルンドベック・アクチエゼルスカベット |
過リン酸化タウに特異的な抗体およびその使用方法
|
|
CA3031390A1
(en)
|
2016-07-28 |
2018-02-01 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Anti- immunoglobulin g aptamers and uses thereof
|
|
US11168148B2
(en)
|
2016-09-07 |
2021-11-09 |
The Regents Of The University Of California |
Antibodies to oxidation-specific epitopes
|
|
RU2019114679A
(ru)
|
2016-11-15 |
2020-12-17 |
Х. Лундбекк А/С |
Средства, пути применения и способы лечения синуклеопатии
|
|
EP3555127B1
(en)
|
2016-12-16 |
2024-12-18 |
H. Lundbeck A/S |
Agents, uses and methods
|
|
WO2018109213A1
(en)
|
2016-12-16 |
2018-06-21 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Aptamers directed against a kappa light chain-containing protein and uses thereof
|
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
EP3559029A2
(en)
|
2016-12-23 |
2019-10-30 |
Bristol-Myers Squibb Company |
Design of therapeutic immunoglobulin g4 for improved bioanalytical and bioprocessing properties
|
|
US10995137B2
(en)
|
2017-01-04 |
2021-05-04 |
H. Lundbeck A/S |
Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases
|
|
US11773182B2
(en)
|
2017-01-05 |
2023-10-03 |
The Johns Hopkins University |
Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)
|
|
KR102787394B1
(ko)
|
2017-07-14 |
2025-03-26 |
화이자 인크. |
MAdCAM에 대한 항체
|
|
US10894833B2
(en)
|
2017-07-20 |
2021-01-19 |
H. Lundbeck A/S |
Agents, uses and methods for treatment
|
|
EP3444275A1
(en)
|
2017-08-16 |
2019-02-20 |
Exiris S.r.l. |
Monoclonal antibody anti-fgfr4
|
|
WO2019075385A1
(en)
|
2017-10-12 |
2019-04-18 |
Board Of Regents, The University Of Texas System |
T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY
|
|
JP7460608B2
(ja)
|
2018-05-07 |
2024-04-02 |
ジェンマブ エー/エス |
抗pd-1抗体と抗組織因子抗体-薬物コンジュゲートとの組み合わせを用いるがんの治療方法
|
|
EA202092136A1
(ru)
|
2018-05-07 |
2021-03-22 |
Генмаб А/С |
Способы лечения рака с помощью комбинации антитела к pd-1 и конъюгата антитела к тканевому фактору и лекарственного средства
|
|
TWI844571B
(zh)
|
2018-10-30 |
2024-06-11 |
丹麥商珍美寶股份有限公司 |
使用抗血管內皮生長因子(vegf)抗體與抗組織因子(tf)抗體-藥物共軛體之組合以治療癌症之方法
|
|
CA3160151A1
(en)
|
2019-11-04 |
2021-05-14 |
Seagen Inc. |
Anti-cd30 antibody-drug conjugates and their use for the treatment of hiv infection
|
|
WO2021090272A1
(en)
|
2019-11-07 |
2021-05-14 |
Genmab A/S |
Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate
|
|
TW202131954A
(zh)
|
2019-11-07 |
2021-09-01 |
丹麥商珍美寶股份有限公司 |
利用鉑類劑與抗組織因子抗體-藥物共軛體之組合來治療癌症之方法
|
|
CA3163358A1
(en)
|
2019-12-03 |
2021-06-10 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins and uses thereof
|
|
BR112022010425A2
(pt)
|
2019-12-03 |
2022-08-23 |
Evotec Int Gmbh |
Proteínas de ligação ao antígeno associadas a interferon para uso no tratamento de infecção por hepatite b
|
|
JP2023523145A
(ja)
|
2020-04-27 |
2023-06-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
リポ蛋白(a)に対するイソ型非依存性抗体
|
|
EP3909601A1
(en)
|
2020-05-11 |
2021-11-17 |
LeukoCom GmbH |
A novel antibody binding specifically to human ceacam1/3/5 and use thereof
|
|
KR20230028492A
(ko)
|
2020-06-29 |
2023-02-28 |
젠맵 에이/에스 |
항-조직 인자 항체-약물 접합체 및 암의 치료에서의 그의 용도
|
|
WO2022003530A1
(en)
|
2020-06-30 |
2022-01-06 |
Fondazione Toscana Life Sciences |
Neutralizing antibodies to sars coronavirus-2
|
|
IT202000015754A1
(it)
|
2020-06-30 |
2021-12-30 |
Fond Toscana Life Sciences |
Antibodies to coronavirus
|
|
MX2023005528A
(es)
|
2020-11-17 |
2023-06-23 |
Seagen Inc |
Metodos de tratamiento del cancer con una combinacion de tucatinib y un anticuerpo anti-pd-1/anti-pd-l1.
|
|
CA3220925A1
(en)
|
2021-06-09 |
2022-12-15 |
Kara Carter |
Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection
|
|
CN118451108A
(zh)
|
2021-10-29 |
2024-08-06 |
思进公司 |
用抗pd-1抗体和抗cd30抗体-药物缀合物的组合治疗癌症的方法
|
|
WO2023094980A1
(en)
|
2021-11-23 |
2023-06-01 |
Fondazione Toscana Life Sciences |
Antibodies to coronavirus
|
|
JP2025515166A
(ja)
|
2022-05-06 |
2025-05-13 |
ジェンマブ エー/エス |
抗組織因子抗体-薬物コンジュゲートを用いたがんの治療方法
|
|
EP4568995A2
(en)
|
2022-08-12 |
2025-06-18 |
Takeda Vaccines, Inc. |
Anti-denv3 antibodies
|
|
US20260167703A1
(en)
|
2022-11-02 |
2026-06-18 |
Takeda Vaccines, Inc. |
A method for determining the infectivity of a virus
|
|
WO2024126293A1
(en)
|
2022-12-13 |
2024-06-20 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection
|
|
WO2024126294A1
(en)
|
2022-12-13 |
2024-06-20 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection
|
|
WO2024126289A1
(en)
|
2022-12-13 |
2024-06-20 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection
|
|
IT202300000924U1
(it)
|
2023-01-23 |
2024-12-22 |
Philomena Dove |
Cucitura all-up leggins seamless
|
|
WO2024213635A1
(en)
|
2023-04-12 |
2024-10-17 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection
|
|
AU2024277829A1
(en)
|
2023-05-19 |
2025-12-04 |
Les Laboratoires Servier |
Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof
|
|
IT202300015579A1
(it)
|
2023-07-25 |
2025-01-25 |
Fond Toscana Life Sciences |
Anticorpi contro covid-19 e altri coronavirus umani
|
|
WO2025046393A1
(en)
|
2023-08-25 |
2025-03-06 |
Fondazione Per L’Istituto Oncologico Di Ricerca (Ior) |
Reagents against human endogenous retroviruses to target cancer cells
|
|
IT202300026115A1
(it)
|
2023-12-06 |
2025-06-06 |
Fond Per L’Istituto Oncologico Di Ricerca Ior |
Una strategia basata su anticorpi che mira ad erg oncogenico attivato nel cancro alla prostata
|
|
EP4635983A1
(en)
|
2024-04-15 |
2025-10-22 |
Ymmunobio AG |
A novel antibody binding specifically to nptxr and use thereof
|